You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

clinical expression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2 Expression and Clinical Pathological Characteristics in

Recruiting
  • HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
  • Collect HER2 expression in prostate cancer patients
  • Jinan, Shandong, China
    Qilu hospital
Nov 17, 2023

Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of

Active, not recruiting
  • Diabetic Nephropathy
  • Grouping based on previous laboratory results, no intervention.
  • Jinan, Shandong, China
    Qianfoshan Hospital
Oct 24, 2023

Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation

Active, not recruiting
  • Diabetic Nephropathy
  • Grouping based on previous laboratory results, no intervention.
  • Jinan, Shandong, China
    Qianfoshan Hospital
Nov 8, 2023

Hepatocellular Carcinoma Trial in Yichang (Sintilimab)

Recruiting
  • Hepatocellular Carcinoma
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Sep 1, 2023

Gene Expression Trial in Nantong (immunohistochemical)

Recruiting
  • Gene Expression
  • Pathological
  • Nantong, Jiangsu, China
    The Affiliated Hospital of Nantong University
Sep 2, 2022

HER2-positive Advanced Breast Cancer Patients Treated With ADC

Recruiting
  • Breast Cancer
  • HER2 expression of circulating tumor cells
  • Beijing, Beijing, China
    The Fifth Medical Center of PLA General Hospital
Apr 18, 2023

HER2-low Advanced Breast Cancer Patients Treated With ADC

Recruiting
  • Breast Cancer
  • HER2 expression of circulating tumor cells
  • Beijing, Beijing, China
    The Fifth Medical Center of PLA General Hospital
Apr 18, 2023

NSCLC Trial in Yichang (Sindillimab)

Completed
  • Non-small Cell Lung Cancer
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Mar 29, 2023

Chronicization of Radiation-induced Acute Intestinal Injury

Not yet recruiting
  • Radiation-induced Intestinal Injury
  • NCRT+TME
  • (no location specified)
Feb 19, 2023

HER2, Colorectal Cancer Trial (Disitamab Vedotin Combined With Fruquintinib)

Not yet recruiting
  • HER2
  • Colorectal Cancer
  • Disitamab Vedotin Combined With Fruquintinib
  • (no location specified)
Dec 21, 2022

Normal Physiology, Healthy Volunteers, Pain Trial run by the NCCIH (Medoc thermal stimulator, Electric shock stimulator, Cold

Recruiting
  • Normal Physiology
  • +2 more
  • Medoc thermal stimulator
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56

Not yet recruiting
  • Acute Myeloid Leukemia
  • bone marrow aspirate and biopsy
  • (no location specified)
Aug 20, 2022

Difficult-to-heal Wounds Trial (OKTO, Standard clinical procedures)

Not yet recruiting
  • Difficult-to-heal Wounds
  • OKTO
  • Standard clinical procedures
  • (no location specified)
Jul 27, 2023

Apical Periodontitis Trial in Giza (Root canal instrumentation, 2.5% NaOCl irrigation)

Completed
  • Apical Periodontitis
  • Root canal instrumentation, 2.5% NaOCl irrigation
  • Giza, Egypt
    Faculty of Dentistry, Cairo University
Jan 18, 2023

Breast Cancer Trial in Guangzhou (Chidamide Plus Toripalimab Plus Paclitaxel)

Recruiting
  • Breast Cancer
  • Chidamide Plus Toripalimab Plus Paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 19, 2023

Childhood Trauma in Schizophrenia: Exploration of Links Between

Recruiting
  • Schizophrenia
  • magnetic resonance imaging (MRI)
  • +2 more
  • Saint-Étienne, France
    CHU de Saint Etienne
Nov 29, 2022

Gastric Cancer, Pancreatic Cancer, Advanced Ovarian Carcinoma Trial (Claudin 18.2 CAR-T)

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • Claudin 18.2 CAR-T
  • (no location specified)
Jul 21, 2022

Clinical Relevance of PSMA Expression in Malignant Gastrointestinal Tumors Trial in Wuerzburg (18F-PSMA PET/CT)

Recruiting
  • Clinical Relevance of PSMA Expression in Malignant Gastrointestinal Neoplasms
  • 18F-PSMA PET/CT
  • Wuerzburg, Bavaria, Germany
    University Hospital Wuerzburg
Sep 15, 2022

Chronicization of Radiation-induced Acute Intestinal Injury

Not yet recruiting
  • Radiation-induced Intestinal Injury
  • NCRT+TME
  • (no location specified)
Feb 19, 2023

COVID-19 in Rheumatic Inflammatory Diseases Under

Active, not recruiting
  • Chronic Inflammatory Rheumatism
  • Biological samples
  • Montpellier, Occitanie, France
    Centre hopsitalier universitaire de Montpellier
Jun 10, 2022

Gastric or Esophagogastric Junction Adenocarcinoma Trial (nimotuzumab plus paclitaxel, plus paclitaxel)

Not yet recruiting
  • Gastric or Esophagogastric Junction Adenocarcinoma
  • nimotuzumab plus paclitaxel
  • placebo plus paclitaxel
  • (no location specified)
Aug 3, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    hongshan Hospital Affiliated to Fudan University
Sep 14, 2023

Hematologic Malignancies Trial in Assiut (CD56)

Recruiting
  • Hematologic Malignancies
  • CD56
  • Assiut, Egypt
  • +1 more
Jul 20, 2022

High-Risk Breast Duct Epithelium

Completed
  • Breast Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 8, 2023